WELCOME TO THE NILE WEBINAR FOR JUNE 2021!

Page created by Ken Larson
 
CONTINUE READING
WELCOME TO THE NILE WEBINAR FOR JUNE 2021!
WELCOME TO THE NILE WEBINAR FOR
              JUNE 2021!
  Immunize Nevada is a nonprofit 501c3 coalition that is widely recognized as
Nevada’s trusted resource for immunization information and community health
outreach for all ages. We accomplish this by fostering education and statewide
       collaboration with a variety of health partners and collaborators.

You may view upcoming web trainings at ImmunizeNevada.org/NILE-webinars

                        Thank you for joining us today!
WELCOME TO THE NILE WEBINAR FOR JUNE 2021!
HOUSEKEEPING ITEMS

Connectivity     Please log back in and we’ll continue
Issues           where we left off.

                 Locate the Q & A box and type them
Have a
                 there. We will address questions
Question?
                 throughout the presentation.

                 Nursing/Pharmacy/CHW CEUs: Complete
CEU              the post-event survey. Certificates will be
Claiming         emailed within one week of the live
                 presentation.

Recording        The recorded webinar and slides will be posted
& Slides         to ImmunizeNevada.org/NILE-webinars.
WELCOME TO THE NILE WEBINAR FOR JUNE 2021!
DISCLAIMER
   Immunize Nevada’s NILE webinars are made possible by the generosity of
   speakers who donate their time and expertise to benefit the coalition. The
     expectation and goal is for community partners to gain knowledge on
immunization/infectious disease-related topics through a non-branded, unbiased
                                  presentation.

The opinions expressed are those of today’s presenter(s) and do not necessarily
           reflect those shared by Immunize Nevada or its partners.
WELCOME TO THE NILE WEBINAR FOR JUNE 2021!
Working with the Successes of
HPV Vaccine in a Time of Rising
   Anti-Vaccine Sentiment

                     Immunize Nevada
                       June 16, 2021

              Richard Moriarty, MD, FAAP
MA Chapter AAP Immunization Initiative Professor of Clinical
            Pediatrics, UMass Medical School
WELCOME TO THE NILE WEBINAR FOR JUNE 2021!
I HAVE NO
FINANCIAL DISCLOSURES.
WELCOME TO THE NILE WEBINAR FOR JUNE 2021!
OBJECTIVES

●   Understand the CDC/ACIP HPV Vaccine recommendations for pre-teens and
    adolescents
●   Describe the current status of HPV-related disease and vaccination efforts
●   Learn how to create a culture of immunization in your practice
●   Describe steps MA took to increase vaccine use
●   Understand the resources and materials available to help your practices
WELCOME TO THE NILE WEBINAR FOR JUNE 2021!
H UMAN PAPILLOMA VIRUS

• >170 different types
• Most types are benign
• Transmitted through breaks in any epidermis
• 16& 18have viral oncogenes and cause most cancers
• Can cause local self-limited infection, or chronic infection, or
  a dysplastic response
• HPV is the most common STD
• 5.5million new infections yearly
• Virus can be passed by someonewho has no symptoms
WELCOME TO THE NILE WEBINAR FOR JUNE 2021!
HPV-CANCER H ISTORY
1950-60s: Cervical cancer more common in women having more
partners and earlier sex

1980s: Zur Hansen HPV 16 & 18 found in cervical cancers; received
Nobel Prize in 2008

1989: HPV16 DNA in tonsillar SCCs

1990s: Frazier & Zhou developed vaccine

2006: HPV-4 licensed in US & Australia for girls

2009: HPV-4 vaccine licensed for boys in US

2014: HPV-9 approved for boys & girls in US
WELCOME TO THE NILE WEBINAR FOR JUNE 2021!
NFID webinar 3/21/2018   6
WELCOME TO THE NILE WEBINAR FOR JUNE 2021!
HPV-ASSOCIATED CANCERS

*J Natl CancerInst.2015Jun;107(6):djv086. doi:10.1093/jnci/djv086
# https://acsjournals.onlinelibrary.wiley.com/doi/full/10.3322/caac.21590
HPV DISEASE CAN AFFECT PREGNANCY

             • Consistent and significant association between HPV and
               preterm birth and premature rupture of membranes

             • May also be associated with intrauterine growth
               restriction, low birth weight, and fetal death

TheJournalofInfectiousDiseases,jiaa054,https://doi.org/10.1093/infdis/jiaa054 February2020
CERVICAL CANCER: JUST THE TIP OF THE HPV ICEBERG

https://www.cdc.gov/hpv/hcp/protecting-patients.htm
HPV-RELATED OROPHARYNGEAL CANCER
Rate of cervical cancer is 3X greater in Alabama, Mississippi, and Arkansas
than in Massachusetts.
HOW DOES HPV GET TRANSMITTED?

• Sexual contact
    • Sexual intercourse
    • Genital-genital
    • Manual-genital                                https://vimeo.com/230653242
                                                      from Kids Plus Pediatrics, Pittsburgh, PA
    • Oral-genital
      • Genital HPV infections can occur from non-penetrative sexual contact
      • Condom use may reduce but not eliminate risk

•   Non-sexual routes
    • vertical: mother-to-infant; juvenile respiratory papillomatosis

Most infected individuals are unaware that they are infected and may
unknowingly spread the virus
H UMAN PAPILLOMA VIRUS VACCINE
Vaccine prevents
  progression
 from infection
    to cancer
log scale
log scale
ADVANTAGES OF STARTING EARLY
• Thinks of HPV vaccine like car seats or bike helmets: start early to protect children
  before “the event”

• Middle school appointments

• Better immune response

• More chances to complete the series

• Lack of exposure

• Prevents at least twice as much cancer

• Up to 40X the antibody level of natural infection

• Only 2 shots instead of 3 shots

• May help remove “sex” from the discussion

• This is a cancer vaccine.
HPV VACCINE IS EFFECTIVE!

•   82% (M) to 93% (F) reduction in genital warts
•   Evidence of herd immunity
•   Decline in cervical pre-cancers
•   HPV vaccine prevents cervical cancer
•   HPV vaccine prevents oropharyngeal infection
•   Some cross-protection from HPV4 against the 5additional strains in HPV-9
HPV VACCINE DECREASES CERVICAL CANCER R ISK
• 1.67million Swedishwomenages 10-30during the period 2006-2017
• Risk of cervicalcancer88% lowerin those whobegan HPV vaccinebeforeage 17
    than in those not been vaccinated
•   Risk of cervicalcancerrose as age of receipt of vaccinerose
•   Recommendation:begin HPV vaccineseries
    BEFORE HPV exposure

    N Engl J Med 2020;383:1340-8.
    DOI:10.1056/NEJMoa1917338
> 270 million doses
                                                          worldwide
                                                        > 120 million doses in US

https://doi.org/10.7326/M20-2726 20 year study of vaccine safety
HPV VACCINE DOES N OT CAUSE OVARIAN FAILURE
    • 199,078 females Kaiser Permanente Northwest 2006-14
    • Part of the Vaccine Safety Datalink
    • 58,871doses of HPV vaccine during study period; ages 11-34y
    • No evidence of increased incidence of POF after HPV immunization
    • POF rate:
         • 1in 1,000 ages of 15and 29
         • 1in 100 ages of 30 and 39
    • No biologic plausibility to believe that vaccine was the cause; HPV disease does not
      cause ovarian failure

PEDIATRICS Volume 142,number 3,September 2018:e20180943
       DOI: https://doi. org/10. 1542/peds. 2018- 0943
SYNCOPE AFTER VACCINATION

  •   62% happens between ages 11-18: VAERS
  •   Most common when Tdap, MCV, and HPV given together
  •   HPV vaccine hurts: 60-80% report some pain
  •   Falls after fainting can cause head injury
  •   Sit or lie down post-vaccines
  •   Wait 15 minutes
  •   Other vaccines hurt too (flu, Tdap, Shingles)

Vaccine 2009 Nov 16;27(49): 6840–6844V
doi: 10.1016/j.vaccine.2009.09.016
VAERS IS A SENTINEL SYSTEM

Dosing errors                                                 Balloon
Admin errors                                                  Bird
Side effects                                                  Drone
Allergic reaction                                             Small plane
Adverse reactions                                             Commercial plane
Rareevents                                                    Hostile enemy

     ● Anyone can report anything to VAERS
     ● A VAERS report does not prove causality
     ● Reports are examined; more information may be obtained to examine
       possible causality
     ● Recent “hold” on AZ vaccine shows system can work to identify rare
       reactions
SAFETY OF HPV VACCINE
              REPORTS OF DEATH H AVE BEEN GREATLY EXAGGERATED

   •   VAERS reports over 3years 2014-2017
   •   7reports of death after HPV vaccine
   •   5heresay reports no data available to confirm death
   •   2 had complete data and autopsy reports
       – 14yo F - HPV/flu vaccines; dissecting aortic aneurysm
       – 16yo M- HPV/HepA vaccines; cerebellar aneurysm
   •   No causal effect of vaccine found
   •   28 million doses of HPV9 distributed during this period

DOI: https://doi.org/10.1542/peds.2019-1791 Pediatrics vol 114;December 2019
HPV VACCINE IS LONG LASTING

   •    >10 years of durable protection from high-risk strains
   •    New study shows durable protection against HPV 16/18for at least 14years
        (Denmark, Iceland, Norway, Sweden)

   •    Some cross-protection from HPV4 against the 5additional strains in HPV-9
   •    HPV9 can prevent up to 92% of HPV-attributable cancers or about 44,000 cancer
        cases per year

Pediatrics 2019Feb;143(2):e20181902.doi:10.1542/peds.2018-1902
https://www.cancer.gov/news-events/cancer-currents-blog/2020/hpv-vaccine-single-dose-long-
term-protection
WHY H AVEN ’T MORE CHILDREN GOTTEN HPV VACCINE?
• Recommendation initially for girls, not boys

• Diseases pediatricians don’t see
• Little information about scope of diseases

• Little information about messaging to parents
• Concerns about safety

• Politics and sex
• Anti-vaccine movement

• Another vaccine at a time of “vaccine overload”

                     BUT now, 15years since approval, we know more
                          about thediseases and the vaccine.
                HPV vaccine is safe, effective and long lasting!
WHAT DO PARENTS WANT TO KNOW?

        • What is HPV disease?
        • Age to start the vaccine?
        • Vaccinate both boys and girls?
        • Vaccine safety and side effects?
        • Why vaccinate those not sexuallyactive?
        • National recommendations?
        • School requirements?
        • Standard of care?

PEDIATRICS DOI:https://doi.org/10,1542/peds.2018-1872
PARENTAL I NTENT:HPV VACCINE FOR CHILDREN

 • Parents of adolescents 13-17 in 2017-2018 NIS-Teen

 • >82,000 parents completed survey

 • 37% unvaccinated for HPV; 58% no intent to vaccinate

       • ID, KS, MI, MT, NE, OK, ND, UT

       •   Reason: safety, not needed, not recommended
 • 11% had had 1dose; 23% had no intent to complete series

       • AK, FL, GA, HI, ID, UT, WV

       •   Reason: not recommended

www.thelancet.com/public-healthVol 5September 2020
DOI:https://doi.org/10.1016/S2468-2667(20)30139-0
I MPROVING VACCINE UPTAKE: MA

•   2002: Christine Baze
•   Team Maureen: 2007; HPV symposium

•   2013: MA DPH awarded CDC grant for
    •   AFIX quality improvement program
•   2013: An Act Establishing the Massachusetts Childhood Vaccine Program
•   www.mass.gov/dph/hpvvax to provide          information for parents & providers
•   #2shots2stopcancer on twitter
•   Seminars provide updates, survivor stories
•   Oral Task Force; toolkits for dental practices
•   MCAAP webinars, CME immunization updates
COLLABORATE WITH OTHERS
                   HTTPS://WWW.MAHPVCOALITION.ORG/

Otolaryngology                     CDC
  OB-GYN            MCAAP
                   Dental
 Social                            MA DPH
 Media
                 Associations

          School Health & CollegeHealth
CME- CEU Seminars
with Cancer Survivors
          Community Health Centers
             Pediatric Practices
                  ASTHO
HPV VACCINE:WHERE DO WE STAND
                           Combined data for boys and girls ages 13-17

              State                       HPV>1                        HPV UTD
              #1 RI*                      91.9%                         78.9%
              #2 ND                       88.8%                         76.9%
              #3 MA                       87.9%                         74.3%
               US                         71.5%                         54.2%
               NV                         68.9%                         52.9%
               MS                         49.5%                         30.5%
                             Healthy People 2020 Goal was 80% UTD
                         NIS-Teen is a random-digit-dial telephone survey
                       https://www.health.nd.gov/immunize/coverage-rates
https://www.cdc.gov/mmwr/volumes/69/wr/mm6933a1.htm?s_cid=mm6933a1_w
                     https://stacks.cdc.gov/view/cdc/91797
Strong Provider Recommendation a Key toNorth
       Dakota’s High Immunization Rate
COVID VACCINE STRATEGIES – USEFUL FOR HPV & OTHER
                R OUTINE VACCINES?
By 2066, less than
                   one woman per year
                       in Australia
                   could be diagnosed
                           with
                     cervical cancer.

                   Lancet Public Health 10/2/2018

NY Times 10/2/18
January 2019

     VACCINE HESITANCY: TOP 10 THREAT
H OW DID WE GET TO THIS POINT?

•   Distrust of government
•   Distrust of big pharma
•   Disappearance of VPDs
•   Magnification of AV beliefs on social media
•   Viral spread of doubt
•   Feeling of loss of control
•   Loss of liberty
•   COVID-19 contagion risk linked to “anti-other”
•   “Operation Warp Speed,” “race,”“finalists”
H OW CAN WE FIX THIS?
                               IT TAKES A VILLAGE
•   Local Health Departments

•   Local School Committee

•   Schools:admin, nurses, PTOs

•   Local - Regional Hospitals, ERs

•   Primary Care Physicians:OB, Peds, FP

•   Health Centers

•   Libraries

•   Press

•   Parents

•   Legislators
Build A Relationship On Trust

      Demonstrate Confidence in Our Vaccines
  Motivational Interviewing - Immunize Colorado
www.immunizecolorado.org ›uploads ›Motivational-I...
TRUST

•   Physicians, nurses, office staff
•   Community leaders
•   Religious leaders
•   Neighbors
•   Relatives
•   Stories
•   Bewilling to listen
VACCINE CONFIDENCE IN Y OUR OFFICES

•   “We immunize”

•   Website, practice letter, handouts, prenatal visits, officeposters

•   Makeclinical resources availablefor staff

•   All staff must be on board with the same message!!!

•   Give strong presumptive recommendation

•   Provide VIS for every vaccine at every visit

•   Know what is in the package inserts
VACCINE CONFIDENCE IN Y OUR OFFICES

•   “Whichvaccines would you like today?”
             vs
•   “Today she is due for these vaccines.”
•   “These are the recommended vaccines to prevent………. I highly recommend
    them.”

•   “These vaccines will prevent…”
•   “These vaccines are standard of care.”
•   “Sameway, same day” Tdap, HPV, MCV4
BUT I’VE HEARD BAD THINGS ABOUT THE HPV VACCINE

    •   Welcome questions and know the answers

    •   Listen to or ask about concerns

    •   “I can see why you might be worried.”

    •   “Would you share what you have read?”

    •   “May I share some information with you?”

    •   “What information would be helpful for you now?”

Amanda Dempsey video and slide set on motivational interviewing
https://www.youtube.com/watch?v=WstEm3zjIJQandCombination of Fact Sheet and Motivational
Interviewing ...
Vaccine Confidence in Your Offices

       • “I immunize my children.”

       • Tell your personal stories about VPDs

       • Messages with urgency less well received

       • Audit your immunization rates (EMR or IIS)

       • Examine strategies that can help improve immunization rates

       • If at first you don’t succeed, try again - up to 35% will change

       • Customized fact sheets

https://www.cdc.gov/vaccines/programs/iqip/at-a-glance.html
CHAMPION

•   Lead the effort
•   Help develop consensus
•   Believein the vaccine
•   Know the package insert
•   Answer questions about vaccine
•   Knows the immunization rates
•   Provides handouts & references
•   Can talk with parents & patients
•   Periodically run coverage reports
•   Decrease missed opportunities
“CHOICE,”“FREEDOM,”“LIBERTY”

  • Long-standing anti-vaccine mantras (autism, safety, religion)

  • Choice: disease vs disease protection

  • “Freedom” and “personal responsibility”

  • Seat belts, car seats, bike helmets save lives, save $$, and protect
    others

  • Jacobson v MA 1905

  • “No one is safe until we are all safe”

https://supreme.justia.com/cases/federal/us/197/11/
WHO PAYS WHEN VPDS OCCUR?

•    MN: 79 cases measles, $2 million
•    NY: 949 cases measles, $8.4 million
•    WA: 72 cases, $3.4 million
•    OR: one tetanus case >$800,000

VPD outbreaks are expensive, lead to time missed from work
and school, and may lead to serious sequellae.

                                                   We all pay!
https://www.cdc.gov/mmwr/volumes/68/wr/mm6809a3.htm?s_cid=mm6809a3_e
Pediatrics April 2021, 147(4) e2020027037; DOI: https://doi.org/10.1542/peds.2020-027037
COMMON QUESTIONS ABOUT HPV VACCINE
  •    HPV vaccine for adults ages 27-45 years?

  •    Vaccine less effective and less cost-effective

  •    Does insurance cover it?

  •    “Shared clinical decision-making”

  •    HPV-9 for those who completed series with HPV-4?

  •    HPV-9 covers 15% more cancers than HPV-4

  •    Series started with HPV-4 can be completed with HPV-9

  •    No recommendation to re-do HPV-4 series with HPV-9

  •    HPV-9 series after completing HPV-4 series may lead to lower antibody response for
       the 5 additional HPV types
CDC: Supplemental information and guidancefor vaccination providersregarding use of 9-valent HPV
cdc.gov/hpv
https://www.nytimes.com/2019/12/11/opin
                                             ion/anti-vaccine-
                                     HPV.html?searchResultPosition=1

https://www.youtube.com/watch?v=R -S1h_pQOFU
R EFERENCES

“Communicatewith Confidence: Talking with Patients about Vaccinesresource list from MA
Department of Public Health and MA ChapterAAP Vaccine Confidence Project
https://hpvroundtable.org/ resources,staff education, suggestionto help
https://mcaap.org/immunization-initiative/immunization-hpv/ link to MA program to increase
HPV uptake;news, material, training, handouts, resources
www.immunize.org very comprehensive site with up to date Vaccine Information Statements,
pictures and videos of vaccine-preventablediseases, handouts for discussing religious concerns,
thimerosal, vaccine ingredients, alternative schedules, vaccine safety,and much more
www.cdc.gov/vaccines/parents/index.html vaccine schedules, safety information, vaccine
ingredients, and a verygood video called “TheJourney of Your Child’s Vaccine.” The information in
this video is also available in a large office-size chart that you can request from CDC; many
printable handouts
http://www.boostoregon.org/peers programto help train community members as vaccine
educators; also a very goodvideo about communicating about vaccines
https://lillianlabs.com/2021/05/26/watch-the-webinar-breaking-through-covid-19-vaccine-
hesitancy
R EFERENCES
www.aap.org/en-us/advocacy-and-policy/aap-health-
initiatives/immunizations/Pages/Immunizations-home.aspx Teaching toolsfor staff;
“HPV:Same way same day”free downloadableappat GooglePlay Store& AppleiTunes
Store
https://zdoggmd.com/ Dr. Zubin Damania https://zdoggmd.com/zpupp-hpv-shot/
AmandaDempseyvideo and slide seton motivationalinterviewing
https://www.youtube.com/watch?v=WstEm3zjIJQandCombinationof Fact Sheetand
MotivationalInterviewing…
Voicesfor Vaccinesparent-run site;manytools and references;sign up for weekly
newsletter: “Thisweekin vaccinehesitancy.”
AAP: sign up for Immunization Newsletter at IZCommunity@listserv.aap.org
https://www.skepticalraptor.com/skepticalraptorblog.php/one-stop-shop-science-myth-
debunking-gardasil/ This columnexplodesall themyths aboutsupposedharms of HPV
vaccine.
LAST MINUTE QUESTIONS &
   HOUSEKEEPING ITEMS REVIEW
            Locate the Q & A box and type them
Have a
            there. We will address as many questions
Question?
            as we can today.

            Nursing/Pharmacy/CHW CEUs: Complete
CEU         the post-event survey. Certificates will be
Claiming    emailed within one week of the live
            presentation.

Recording   The recorded webinar and slides will be
& Slides    posted to ImmunizeNevada.org/nile-webinars.
You can also read